Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.

Cancer treatment and research - 1 Jan 2001

Preisler H D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human
Share to Gene Expression Regulation, Leukemic
Share to Hematopoiesis
Share to Leukemia, Myeloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Disorders

Share to Neoplasms, Second Primary

Source

Identifiers

PMID: 11702600

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.PMID 11702600Read ↗

MDS and secondary AML: an evolutionary perspective.Semantic proximity Read ↗

Secondary and therapy-related acute myeloid leukemias: Overlapping features, distinct trajectories.Semantic proximity Read ↗

Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.Semantic proximity Read ↗

Dynamic hematological disease: a reviewSemantic proximity Read ↗

Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancerSemantic proximity Read ↗

[Pathophysiology of myelodysplastic syndromes].Semantic proximity Read ↗

From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers.Semantic proximity Read ↗

Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndromeSemantic proximity Read ↗

The changing classification of myelodysplastic syndromes: what's in a name?Semantic proximity Read ↗

Malignant progression of preleukemic disorders.Semantic proximity Read ↗

[Pathogenesis and biology of leukemias].Semantic proximity Read ↗

Germline predispositions to myeloid malignancies: Across the lifespan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.